Pegatron Corp (和碩), one of Apple Inc’s iPhone assemblers, yesterday said it is planning to expand manufacturing sites in Vietnam, India and North America to meet customer demand for production diversification, amid supply chain chaos attributable to the fallout of the COVID-19 pandemic.
The unpredictable effects of COVID-19 and unstable supply chains have increased uncertainty worldwide regarding consumer demand and the shipping of products, Pegatron said in its annual report.
“Pegatron will continue monitoring the supply of key components and working closely with its suppliers to optimize capacity allocations,” the company said.
Photo: Huang Hao-chen, Taipei Times
The remarks came as the firm held its annual general meeting in Taipei, where shareholders approved the distribution of a cash dividend of NT$5 per share.
That represented a payout ratio of 64.85 percent based on the company’s earnings per share of NT$7.71 last year.
Pegatron’s board of directors last month approved a plan to invest an additional US$50.61 million to expand its manufacturing hub in North America, the company said in a regulatory filing.
Pegatron said it had already planned to invest US$164 million on production lines in North America so that it could accommodate an increase in orders in the region.
The company has factories in Taoyuan, as well as operations in Mexico, Indonesia and the Czech Republic, while China is still its most important manufacturing hub, with factories in Kunshan, Suzhou, Shanghai and Chongqing.
Pegatron expects an increase in demand for information technology products, especially commercial PCs, as people gradually return to the office, the annual report said, adding that the launch of Microsoft Corp’s Windows 11 operating system would stimulate PC replacement demand.
As communications products, such as smartphones, are affected by seasonal cycles, Pegatron said it plans to boost production efficiency and improve management to navigate the industry’s ups and downs.
Last quarter, communication products were the biggest revenue contributor, accounting for 60 percent of total revenue, the company said.
This year, Pegatron expects its automotive electronics business to contribute more revenue, thanks to an increase in orders.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS